Journals / Türk Kardiyoloji Derneği Arşivi / 2004 / Cilt: 32 - Sayı: 9

Are the parameters of inflammation a measure of success of thrombolytic treatment in acute myocardial infarction?

İnflamasyon parametreleri akut miyokard infarktüsünde trombolitik tedavinin başarısını gösteriyor mu?

Pages
603–610
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum hsCRP level measured before thrombolytic therapy in patients with AMI with ST elevations is a practical and reliable method in determining the efficacy of thrombolytic treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the present study, we investigated the role of pre-treatment highly sensitive C reactive protein (hsCRP) and serum amyloid A (SAA) levels in predicting the success of thrombolytic treatment in patients with acute ST ele¬vation pect to the initial ST elevation was accepted as complete resolution, while resolution values of respectively 31-69% and 0-30% were designated as moderate and weak resolution.
📊
Key Findings & Data:On their 5th day of hospitalization, a se¬cond serum sample was collected from all patients for the determination ofhsCRP and SAA values.
💡
Conclusion & Impact:Serum hsCRP level measured before thrombolytic therapy in patients with AMI with ST elevations is a practical and reliable method in determining the efficacy of thrombolytic treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In the present study, we investigated the role of pre-treatment highly sensitive C reactive protein (hsCRP) and serum amyloid A (SAA) levels in predicting the success of thrombolytic treatment in patients with acute ST ele¬vation pect to the initial ST elevation was accepted as complete resolution, while resolution values of respectively 31-69% and 0-30% were designated as moderate and weak resolution. On their 5th day of hospitalization, a se¬cond serum sample was collected from all patients for the determination ofhsCRP and SAA values. Their coro¬nary angiography and TIMIflow patterns were also evaluated. There was an inverse-relationship between the initial hsCRP and SAA levels on one hand and the ST resolution after thrombolytic treatment on the other, which persisted at the 5th day after presentation. Complete resolution was predicted with a sensitivity of 67% and a specificity of 74% in patients with hsCRP levels below 3.5 mgldl. Conversely, for patients with hsCRP values above 7.0 mgldl, poor ST resolution was predicted with a sensitivity of 70% and a specificity of 8.8%. Serum hsCRP level measured before thrombolytic therapy in patients with AMI with ST elevations is a practical and reliable method in determining the efficacy of thrombolytic treatment.

Özet

Akut ST yükselmeli miyokard infarktüsünde (AMİ) yetersiz koroner reperfüzyon kötü prognoz ile ilişkilidir. Bu nedenle trombolitik tedavinin yeterli reperfüzyon sağlayıp sağlayamadığının hızlı ve pratik bir yöntemle kontrol edilmesi önemlidir. Göğüs ağrısının sona ermesi ve elektrokardiyografide (EKG) yükselmiş ST segmentinde çökme olması klinikte en sık ve kolay uygulanan yöntemlerdir. Bu çalışmada akut ST yükselmeli AMİ hastalarında uygulanan trombolitik tedavinin etkinliğini saptamada trombolitik öncesi incelenen yüksek hassas C-reaktif protein (hsCRP) ve serum amiloid A (SAA) düzeylerinin yeri araştırıldı. ST yükselmeli AMİ tanısıyla kliniğimize yatırılan yaşları 28-70 arası (ortalama 54.8 ± 9.4 yıl), ardışık 42 hasta (4 kadın, 38 erkek) çalışmaya dahil edildi. Hastalardan CK-MB, Troponin T, lipid düzeyleri, hsCRP ve SAA için serum örnekleri alındıktan sonra trombolitik tedavi uygulandı. Tedavinin 0. ve 3. saatinde EKG'ler çekildi ST segment yükseklikleri değerlendirildi, %70 ve üzeri ST rezolüsyonu tam, %31-69 orta ve %0-30 hafif olarak kabul edildi. Yatışların 5. gününde hassas hsCRP ve SAA için ikinci kez serum örnekleri alındı. Koroner anjiyografileri yapıldı ve TIMI akımları değerlendirildi. Trombolitik öncesi bakılan hsCRP ve SAA düzeyleri ile ST rezolüsyonu arasında negatif bir ilişki mevcuttu ve bu ilişki 5. gün devam etmekteydi. Trombolitik öncesi bakılan hsCRP düzeyi 3.5 mg/dl'nin altında ise %67 duyarlılık ve %74 özgüllük ile ST rezolüsyonunun yeterli olacağını tahmin ederken, 7.0 mg/dl'nin üzerinde ise %70 duyarlılık ve %88 özgüllük ile rezolüsyon olamayacağını tahmin ettiği görüldü. Sonuç olarak ST yükselmeli AMİ'de trombolitik öncesi incelenen serum hsCRP düzeyi uygulanacak trombolitik tedavinin etkinliğini göstermede kullanılabilecek kolay ve güvenilir bir yöntemdir.

🔖

Cite This Article

KOÇ, M., USAL, A., DÖNMEZ, Y., DEMİRTAŞ, M., ŞAN, M., KANADAŞI, M., DEMİR, M., AVKAROĞULLARI, M., ALHAN, C., İNAL, T., ÇAYLI, M., AKPINAR, O. (2022). Are the parameters of inflammation a measure of success of thrombolytic treatment in acute myocardial infarction?. Türk Kardiyoloji Derneği Arşivi, Cilt: 32 - Sayı: 9, 603–610. https://ajindex.com/articles/633799

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Simes RJ, Topol EJ, Holmes DR, et al: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995
  2. 8 2. White HD, Norris RM, Brown MA, et al: Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987
  3. 5 3. Dissmann R, Schroder R, Busse U, et al: Early assessment of outcome by ST-segment analysis after thrombolytic therapy in acute myocardial infarction. Am Heart J 1994
  4. 7 4. Nicolau JC, Maia LN, Vítola J, et al: ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction. Am J Cardiol 2003
  5. 3 5. Shah A, Wagner GS, Granger CB, et al: Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol 2000
  6. 72 6. French JK, Andrews J, Manda SO, Stewart RA, McTigue JJ, White HD: Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction. Am Heart J 2002
  7. 71 7. Abdelmouttaleb I, Danchin N, Ilardo C, et al: C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999
  8. 51 8. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999
  9. 20 9. Kinjo K, Sato H, Ohnishi Y, et al: Acute Coronary Insufficiency Study (OACIS) Group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 2003
  10. 5 10. Suleiman M, Aronson D, Reisner SA, et al: Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003
  11. 701 11. Liuzzo G, Biasucci LM, Gallimore JR, et al: The prognostic value of C reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994
  12. 24 12. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000
  13. 69 13. Schroder R, Dissmann R, Bruggemann T, et al: Extent o